Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
you are here: HomeNewsAartidrugs
Jump to
  • Aarti Drugs expects over Rs 700cr revenue in FY12 Apr 13, 2011 04:38 PM IST

    Aarti Drugs expects over Rs 700cr revenue in FY12

    Harshit Savla, MD of Aarti Drugs, in an interview with CNBC-TV18’s Gautam Broker and Latha Venkatesh, spoke about the recent happenings in his company and the road ahead.